0001076167-11-000033.txt : 20111209
0001076167-11-000033.hdr.sgml : 20111209
20111209140536
ACCESSION NUMBER: 0001076167-11-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111207
FILED AS OF DATE: 20111209
DATE AS OF CHANGE: 20111209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADOLOR CORP
CENTRAL INDEX KEY: 0001076167
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 311429198
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 PENNSYLVANIA DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
MAIL ADDRESS:
STREET 1: 700 PENNSYLVANIA DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Magni Guido
CENTRAL INDEX KEY: 0001437150
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30039
FILM NUMBER: 111253016
MAIL ADDRESS:
STREET 1: 700 PENNSYLVANIA DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-12-07
0
0001076167
ADOLOR CORP
ADLR
0001437150
Magni Guido
700 PENNSYLVANIA DRIVE
EXTON
PA
19341
1
0
0
0
Adolor Common Stock (ADLR)
2011-12-07
4
M
0
30000
1.77
A
35141
D
Adolor Common Stock (ADLR)
2011-12-07
4
M
0
20000
2.2
A
55141
D
Adolor Common Stock (ADLR)
2011-12-07
4
M
0
20000
1.6
A
75141
D
Adolor Common Stock (ADLR)
2011-12-07
4
M
0
30000
1.39
A
105141
D
Adolor Common Stock (ADLR)
2011-12-07
4
M
0
30000
1.5
A
135141
D
Adolor Common Stock (ADLR)
2011-12-07
4
U
0
135141
D
0
D
Stock Option (right to buy)
1.77
2011-12-07
4
M
0
30000
0
D
Adolor Common Stock (ADLR)
30000
0
D
Stock Option (right to buy)
2.2
2011-12-07
4
M
0
20000
0
D
Adolor Common Stock (ADLR)
20000
0
D
Stock Option (right to buy)
1.6
2011-12-07
4
M
0
20000
0
D
Adolor Common Stock (ADLR)
20000
0
D
Stock Option (right to buy)
1.39
2011-12-07
4
M
0
30000
0
D
Adolor Common Stock (ADLR)
30000
0
D
Stock Option (right to buy)
1.5
2011-12-07
4
M
0
30000
0
D
Adolor Common Stock (ADLR)
30000
0
D
Shares are tendered pursuant to the tender offer commenced with respect to the Issuer's shares (the "Offer") at a purchase price of $4.25 per share in cash, plus one non-transferable contingent payment right for each share, which shall represent the right to receive up to $4.50 in cash subject to the fulfillment of certain conditions and/or the attainment of certain milestones, upon the terms and subject to the conditions set forth in the Offer.
Transaction pertains to the vesting of unvested stock options and the issuance of shares of common stock underlying certain vested stock options, pursuant to the terms of the Agreement and Plan of Merger, dated as of October 24, 2011, by and among the Issuer, FRD Acquisition Corporation and Cubist Pharmaceuticals, Inc. and the related Offer.
/s/ John M. Limongelli, Attorney-in-fact for Guido Magni
2011-12-09